ライフサイエンスコーパス: thyroglobulin

1 ung NODCCR7(ko/ko) mice by immunization with thyroglobulin.

2 s, perhaps by augmenting the antigenicity of thyroglobulin.

3 particularly in patients with elevated serum thyroglobulin.

4 oid peroxidase, sodium iodine symporter, and thyroglobulin.

5 nding to the fucose-containing glycoprotein, thyroglobulin.

6 l surface to catalyze iodination of secreted thyroglobulin.

7 antigen, neu, and an unrelated self-antigen, thyroglobulin.

8 that crucially involves the iodoglycoprotein thyroglobulin.

9 an influence on tyrosine sulfate content of thyroglobulin.

10 bonucleoprotein, four to histone and none to thyroglobulin.

11 ession of MHC class II, and up-regulation of thyroglobulin.

12 osylation sites in the homologous segment of thyroglobulin.

13 ereby allowing prompt thyroxine release from thyroglobulin.

14 ylococcus enterotoxin B, ribonuclease A, and thyroglobulin.

15 multiple sites within its protein precursor thyroglobulin.

16 gative DTC patients with elevated and rising thyroglobulin.

17 gative DTC patients with elevated and rising thyroglobulin.

18 ive congenital hypothyroidism with deficient thyroglobulin.

19 of recombinant human thyrotropin-stimulated thyroglobulin.

20 ha(1)-acid glycoprotein, immunoglobulin, and thyroglobulin.

21 of the parameters evaluated, including serum thyroglobulin.

22 yoglobin (17 kDa), transferrin (77 kDa), and thyroglobulin (670 kDa) proteins was accomplished in a s

23 In addition, four of 22 tumors co-express thyroglobulin (a non-neuroendocrine follicular epithelia

24 h post-translational processing of wild-type thyroglobulin (a secretory glycoprotein) as well as endo

25 amma also inhibited 4-fold the expression of thyroglobulin, a native cAMP-responsive gene, in primary

26 Thyroid hormonogenesis requires secretion of thyroglobulin, a protein comprising Cys-rich regions I,

27 Serum thyroglobulin Abs decreased in the MYMD-1 group.

28 er than GRP94 did not detectably differ, and thyroglobulin achieved transport competence in both kind

29 ng the IgG through a series of melibiose and thyroglobulin-agarose columns.

30 Among the 75 patients in whom thyroglobulin analysis was performed, 81% had decreased

31 N-gamma(-/-) donor mice activated with mouse thyroglobulin and anti-IL-2R mAb induced severe granulom

32 carcinoma (DTC) patients with elevated serum thyroglobulin and both negative radioiodine imaging and

33 Preincubation of cells with glycoproteins (thyroglobulin and fetuin), but not simple sugars, blocks

34 a specific combination of polymorphisms for thyroglobulin and HLA-DR markedly increases the odds rat

35 found that supplementation reduced maternal thyroglobulin and in 3 RCTs, it prevented or diminished

36 ed splenocytes activated in vitro with mouse thyroglobulin and interleukin (IL)-12.

37 ed splenocytes activated in vitro with mouse thyroglobulin and interleukin-12.

38 Overexpression of TTF1 increased thyroglobulin and sodium/iodide symporter mRNA levels, c

39 n, abolished hormone-regulated expression of thyroglobulin and the sodium/iodide symporter.

40 tion in vivo, CBA/J mice were immunized with thyroglobulin and then injected with IFN-gamma and TNF-a

41 cement is specific for TSHR Abs, with Abs to thyroglobulin and thyroid peroxidase remaining unchanged

42 se spontaneously occurring autoantibodies to thyroglobulin and thyroid peroxidase were unaffected.

43 develops in NOD.H2(h4) mice associated with thyroglobulin and thyroid-peroxidase, but not TSHR, Abs.

44 All offspring developed Abs to thyroglobulin and thyroid-peroxidase.

45 the substrate for thyroid hormone synthesis (thyroglobulin) and the ability to recover and retain int

46 t chain did not cleave radiolabeled albumin, thyroglobulin, and annexin V under conditions that readi

47 inent early iodination sites in this part of thyroglobulin, and because the N-terminal region was pre

48 ated with circulating autoantibodies against thyroglobulin, and development of primary hypothyroidism

49 histologic subtype of tumor, levels of serum thyroglobulin, and morphologic findings on full-dose CT

50 storis, hen ovalbumin, bovine fetuin, bovine thyroglobulin, and several invertase preparations from w

51 serum sample have been demonstrated for anti-thyroglobulin (anti-TG) and anti-thyroid peroxidase (ant

52 d spleen cells activated in vitro with mouse thyroglobulin, anti-IL-2R, and IL-12.

53 3), and autoimmunity [thyroid peroxidase and thyroglobulin antibodies (TPOAb and TgAb, respectively)]

54 In long-term follow-up of DTC patients with thyroglobulin antibodies, 96% with undetectable TSHR mRN

55 (e.g., elevated thyroglobulin level without thyroglobulin antibodies, positive results on recent fin

56 globulin concentrations or anti-DNA and anti-thyroglobulin antibodies.

57 aphy, or elevated levels of thyroglobulin or thyroglobulin antibodies.

58 of the 652 patients (95%) without detectable thyroglobulin antibodies.

59 ovide an overview of the clinical utility of thyroglobulin antibody (TgAb) measurements in the manage

60 molecular weight complex at the position of thyroglobulin (approximately 670 kDa).

61 and CdtC-II(Ec) bind immobilized fetuin and thyroglobulin as well as fucose and to a lesser degree N

62 of TRA, parathyroid hormone, calcitonin, and thyroglobulin, as part of an effort to better define the

63 of the asialoglycoprotein receptor (ASGP-R), thyroglobulin, asialothyroglobulin, and antibody against

64 iter with defective thyroglobulin, GRP94 and thyroglobulin associate in a protracted fashion.

65 id glands in Mct8-KO mice contained more non-thyroglobulin-associated T4 and triiodothyronine than di

66 e present the structure of full-length human thyroglobulin at a resolution of approximately 3.5 angst

67 is not investigating the standardization of thyroglobulin at the present time.

68 nd inhibited further increases in anti-mouse thyroglobulin autoantibodies when administered to mice t

69 une thyroiditis (SAT) and produce anti-mouse thyroglobulin autoantibodies when they receive 0.05% NaI

70 letion also resulted in increased anti-mouse thyroglobulin autoantibody responses and increased expre

71 nt of SAT, development of SAT and anti-mouse thyroglobulin autoantibody responses were reduced.

72 Tg(+) mice always had reduced anti-mouse thyroglobulin autoantibody responses, compared with Tg(-

73 Most Tg mice produced less anti-mouse thyroglobulin autoantibody than did wild type (WT) mice.

74 Ferritin, folate, cobalamin, zinc, and thyroglobulin averaged 1.57-6.75 times higher and retino

75 The analysis of monoclonal antibodies, thyroglobulin, bacteriophage Qbeta virus-like particles

76 yr5, the most important hormonogenic site of thyroglobulin, because Tyr5 and Tyr130 are proximate, be

77 fter thyroidectomy and radioiodine ablation, thyroglobulin becomes a sensitive marker for the presenc

78 or alpha-Gal-containing analytes CTX, bovine thyroglobulin (Bos d TG), and human serum albumin (HSA)-

79 the Engelbreth-Holm-Swarm sarcoma and bovine thyroglobulin, both of which contain multiple Galalpha1,

80 letion did not alter the balance of free vs. thyroglobulin-bound I(-) in the thyroid (distinguished u

81 glands of TSHR-KO mice produced uniodinated thyroglobulin, but the ability to concentrate and organi

82 The same mice were also exposed to mouse thyroglobulin by chronic i.v. injections.

83 This reflects the regulation of thyroglobulin by the negative feedback loop of the Hypot

84 stimulates both uptake in and production of thyroglobulin by thyroid cells and the results are compa

85 Thyroglobulin can be measured in either serum or dried b

86 induced diabetes of youth, and misfolding of thyroglobulin can result in autosomal recessive congenit

87 -free survival, safety, and changes in serum thyroglobulin concentration.

88 The serum thyroglobulin concentrations and the prevalence of sympt

89 lysis was performed, 81% had decreased serum thyroglobulin concentrations during treatment, as compar

90 Serum thyroglobulin concentrations increased in 15 of 35 teste

91 Upon thyroglobulin delivery from thyrocytes to the follicular

92 Truncated thyroglobulin devoid of the ChEL domain was incompetent

93 nding, we have studied recombinant nonmutant thyroglobulin expressed in control Chinese hamster ovary

94 l lines with DLCs robustly restored hNIS and thyroglobulin expression and iodide uptake capacity.

95 able to prevent, and to reverse, the loss of thyroglobulin expression which occurs normally in TSH-de

96 n of colonies with epithelial morphology and thyroglobulin expression, capable of 10 - 15 population

97 um-iodide symporter but was not required for thyroglobulin expression, suggesting that the thyroid ho

98 SH-stimulated changes in cell morphology and thyroglobulin expression, while RasG37 had no effect on

99 in humans and rodents; these mutations block thyroglobulin from exiting the ER and induce ER stress.

100 in (NLGN) and associated with autism and the thyroglobulin G2320R (G221R in NLGN) mutation responsibl

101 thyrocytes, under the control of the medaka thyroglobulin gene promoter.

102 localized GRINA to band 8q24, distal to the thyroglobulin gene.

103 tiation (for example, thyroid peroxidase and thyroglobulin genes).

104 so expressed the sodium iodide symporter and thyroglobulin genes.

105 congenital hypothyroid goiter with defective thyroglobulin, GRP94 and thyroglobulin associate in a pr

106 as phosphatidylserine, myelin basic protein, thyroglobulin, histone, insulin, cytochrome C, and beta-

107 Three developmental promoters (thyroglobulin, Hox2.6 and Myf5) were then sequentially i

108 elopment of SAT and production of anti-mouse thyroglobulin IgG1 autoantibodies.

109 l activity as a transcriptional regulator of thyroglobulin in 1989, the bulk of the ensuing research

110 oexpression of secretory ChEL with truncated thyroglobulin increased intracellular folding, promoted

111 in mice undergoing TUBO tumor rejection and thyroglobulin injection than in those experiencing eithe

112 The overall structure of thyroglobulin is conserved in all vertebrates.

113 NKX2.1, while the thyroid hormone precursor thyroglobulin is expressed at comparable levels to tissu

114 However, the thyroid-derived protein thyroglobulin is increasingly being used for this purpos

115 a central intrafollicular compartment, where thyroglobulin is iodinated to form the protein precursor

116 xenoantibodies and reactive with epitopes of thyroglobulin, laminin, and heparan sulfate proteoglycan

117 duce thyroid hormone at the acceptor site in thyroglobulin, leaving dehydroalanine or pyruvate at the

118 94% of hypothyroid patients) and stimulated thyroglobulin less than 2 ng/ml (95%, euthyroid; 96%, hy

119 A negative Thyrogen-stimulated thyroglobulin level has a negative predictive value of u

120 fter ablation and also an undetectable serum thyroglobulin level in the absence of antithyroglobulin

121 unnecessary to repeat a Thyrogen-stimulated thyroglobulin level in the surveillance of patients with

122 al evidence of disease included a suppressed thyroglobulin level of less than 1 ng/mL and a stimulate

123 level of less than 1 ng/mL and a stimulated thyroglobulin level of less than 2 ng/mL, rhTSH-assisted

124 quent in patients with a postoperative serum thyroglobulin level of more than 1 ng per milliliter dur

125 was normal in 652 (95%), and the stimulated thyroglobulin level was 1.0 ng per milliliter or less in

126 f having metastasis from DTC (e.g., elevated thyroglobulin level without thyroglobulin antibodies, po

127 nagement of selected cases regardless of the thyroglobulin level.

128 disease; all patients had decreases in serum thyroglobulin levels (mean reduction, 89%).

129 recurrent or metastatic disease with rising thyroglobulin levels (n = 39).

130 ultrasound, I whole body scan, and/or serum thyroglobulin levels for recurrence at the treatment sit

131 ient group and for those patients with serum thyroglobulin levels of less than 5, 5-10, and more than

132 The sensitivities of 18F-FDG PET/CT at serum thyroglobulin levels of less than 5, 5-10, and more than

133 ation, 61 consecutive patients with elevated thyroglobulin levels or a clinical suspicion of recurren

134 Thyroglobulin levels tended to be higher in patients wit

135 w improved understanding of the use of serum thyroglobulin levels to predict future risk of recurrenc

136 venteen (95%) of 19 patients for whom serial thyroglobulin levels were available showed a marked and

137 Serum thyroglobulin levels were concurrently determined by rad

138 Thyroglobulin levels were significantly elevated after r

139 ilable showed a marked and rapid response in thyroglobulin levels with a mean decrease of 70%.

140 both negative 131I WBS findings and elevated thyroglobulin levels.

141 ive diagnostic radioiodine scintigraphy, and thyroglobulin levels.

142 operative findings, pathology, imaging, and thyroglobulin levels.

143 e-stranded and double-stranded DNA, insulin, thyroglobulin, LPS, influenza virus, and Borrelia burgdo

144 ration of region I is a limiting step in the thyroglobulin maturation process, and this step is facil

145 Thyroglobulin may prove to be a useful biomarker for bot

146 .7%), zinc (mean: +2.3%; 95% CI: 0.5, 4.2%), thyroglobulin (mean: +20.1%; 95% CI: 9.0, 32.2%) and thy

147 ed strategies rely primarily on serial serum thyroglobulin measurements combined with cervical ultras

148 al neck ultrasound scans and 6-monthly serum thyroglobulin measurements.

149 catalytic (esterases) and the noncatalytic (thyroglobulin) members of the esterase/lipase family of

150 mice permit thyroiditis induction with mouse thyroglobulin (mTg) after depleting regulatory T cells (

151 Spleen cells from mouse thyroglobulin (MTg) and LPS-primed IL-4(+/+) and IL-4(-/

152 autoimmune thyroiditis (SAT) and anti-mouse thyroglobulin (MTg) autoantibodies, the levels of which

153 y T and B cells and production of anti-mouse thyroglobulin (MTg) autoantibody.

154 They produced little anti-mouse thyroglobulin (MTg) IgG1, but had levels of anti-MTg IgG

155 Relative to mouse thyroglobulin (mTg) immunized controls, mTg-immunized mi

156 responses to human ErbB-2 (Her-2) and mouse thyroglobulin (mTg) were tested in transgenic mice expre

157 Recipients of mouse thyroglobulin (MTg)-primed spleen cells activated in the

158 mice with autoimmune thyroiditis using mouse thyroglobulin (mTg)-pulsed anti-CTLA-4 agonistic Ab-coat

159 athological features can be induced by mouse thyroglobulin (MTg)-sensitized spleen cells activated in

160 regulatory T cells that could suppress mouse thyroglobulin (mTg)-specific T cell responses in vitro,

161 rat erbB-2 (neu) and another self Ag, mouse thyroglobulin (mTg).

162 Administration of self-antigen (mouse thyroglobulin; mTg) loaded multi-ligand DCs caused hypor

163 Since thyroglobulin, no new blood tests for differentiated thy

164 Both proinsulin and thyroglobulin normally form homodimers; the mutant versi

165 neck ultrasonography, or elevated levels of thyroglobulin or thyroglobulin antibodies.

166 patient sera with FcepsilonRIalpha, but not thyroglobulin or thyroid peroxidase, resulted in the dec

167 presence of antibodies to thyroperoxidase or thyroglobulin, or thyroid-stimulating hormone receptor a

168 , cepharanthine blocked T-cell activation by thyroglobulin peptides, in particular Tg.2098 in mice th

169 expressed in Abs formed on immunization with thyroglobulin, pneumococcal polysaccharide, and ssDNA-me

170 as used to then identify its location in the thyroglobulin polypeptide chain.

171 Patients who are thyroglobulin-positive but radioiodine-negative or who h

172 hat further assessment of 131I WBS-negative, thyroglobulin-positive patients by 18F-FDG PET/CT may ai

173 Thyroglobulin (precursor for thyroid hormone synthesis)

174 t not O-linked carbohydrates from fetuin and thyroglobulin prevents binding of CdtA-II(Ec) and CdtC-I

175 at transgenic mice expressing CCL21 from the thyroglobulin promoter (TGCCL21 mice) have significant l

176 irus serotype 8 (AAV8) with a liver-specific thyroglobulin promoter was used to stably express human

177 ice expressing TGF-beta under control of the thyroglobulin promoter were generated to assess the role

178 e (HSVI-TK) is driven in thyrocytes from the thyroglobulin promoter, the drug Ganciclovir causes the

179 e of CD97, we produced a transgenic model of thyroglobulin promoter-driven CD97 expression.

180 cells of transgenic FVB/N mice with a bovine thyroglobulin promoter.

181 expression of IFN-alpha under control of the thyroglobulin promoter.

182 Functional experiments show that the thyroglobulin protein-altering variants P118L and G67S i

183 DIT was coupled to porcine thyroglobulin (PTg) with a molar ratio of 205:1.

184 l iodine uptake restoration with significant thyroglobulin reduction after radioactive iodine therapy

185 tions in the ChEL domain impaired folding of thyroglobulin region I-II-III.

186 Secretion of mature thyroglobulin requires extensive folding and glycosylati

187 , and 0.9980 for myoglobin, transferrin, and thyroglobulin, respectively, were obtained.

188 ere obtained for myoglobin, transferrin, and thyroglobulin, respectively.

189 protein product bound to IGFBP-2 through the thyroglobulin-RGD region of the C terminus of IGFBP-2.

190 DR3 by separately treating 20 purified human thyroglobulin samples with cathepsins B, D, or L, lysoso

191 tein-altering variants P118L and G67S impact thyroglobulin secretion.

192 ctions between regions that are required for thyroglobulin secretion.

193 mune thyroiditis (G-EAT) is induced by mouse thyroglobulin-sensitized spleen cells activated in vitro

194 mune thyroiditis (G-EAT) is induced by mouse thyroglobulin-sensitized splenocytes activated in vitro

195 mune thyroiditis (G-EAT) is induced by mouse thyroglobulin-sensitized splenocytes activated in vitro

196 n of an alpha-Gal-containing protein, bovine thyroglobulin, significantly reduced the IgE response.

197 ression of the thyroid-specific target genes thyroglobulin, sodium iodide symporter, thyroperoxidase,

198 These mice produced thyroglobulin-specific antibody and IFN-gamma-secreting

199 mma(-/-) mice produced lower levels of mouse thyroglobulin-specific autoantibodies after immunization

200 ultifactorial analysis identified stimulated thyroglobulin (sTg) as the sole independent risk factor.

201 roid slices, isolated and iodinated the [14C]thyroglobulin (Tg I), separated its N-terminal approxima

202 Nonlabeled thyroglobulin (Tg II) was isolated from the same glands

203 cal synergism between amino acid variants in thyroglobulin (Tg) and specific HLA-DR3 pocket sequence

204 in 2 known overlapping protein-coding genes, thyroglobulin (TG) and Src-like adaptor (SLA).

205 unction (as shown by increased expression of thyroglobulin (Tg) and the sodium/iodide symporter).

206 Autoantibodies to thyroglobulin (Tg) are a prominent feature of the two au

207 ans and association studies have established thyroglobulin (TG) as a major AITD susceptibility gene.

208 dal T4 production results from iodination of thyroglobulin (TG) at residues Tyr(5) and Tyr(130), wher

209 quantifying three forms of unlabeled, human thyroglobulin (Tg) by bottom-up protein analysis.

210 Follicular thyroglobulin (TG) decreases expression of the thyroid-r

211 In vertebrates, the thyroglobulin (Tg) gene product must be exported to the

212 The 8q24 locus, which contains the thyroglobulin (Tg) gene, was previously shown to be stro

213 erminal cholinesterase-like (ChEL) domain of thyroglobulin (Tg) has been identified as critically imp

214 t factor by binding to the secretory protein thyroglobulin (Tg) in the ER, thereby facilitating its s

215 tric lipase (LIPF) in stomach carcinoma, and thyroglobulin (TG) in thyroid carcinoma.

216 We recently showed that thyroglobulin (Tg) is a heparin-binding protein and that

217 When thyroglobulin (Tg) is endocytosed by thyrocytes and tran

218 Thyroglobulin (Tg) is the macromolecular precursor of th

219 Thyroglobulin (TG) is the protein precursor of thyroid h

220 ted thyroid carcinoma, based on an increased thyroglobulin (Tg) level and negative neck ultrasound (U

221 Thyroglobulin (Tg) levels and/or neck ultrasounds were p

222 Serum thyroglobulin (Tg) levels were measured while patients w

223 We also identified 5 thyroglobulin (Tg) peptides that bound to DRbeta1-Arg74.

224 Follicular thyroglobulin (TG) selectively suppresses the expression

225 tudy, we show that the previously identified thyroglobulin (Tg) T cell epitope p2549-2560 containing

226 n the apical surface of thyroid cells, binds thyroglobulin (Tg) with high affinity in solid phase ass

227 nated tyrosine residues within the precursor thyroglobulin (TG), a 660-kDa homodimer of the thyroid g

228 f secretory proteins, we studied the fate of thyroglobulin (Tg), a large oligomeric secretory glycopr

229 n reflection mode for the detection of human Thyroglobulin (TG), a protein marker of differentiated t

230 thyrocytes, GRP94 interacts transiently with thyroglobulin (Tg), and in thyrocytes of animals sufferi

231 permits disease induction with heterologous thyroglobulin (Tg), but unlike conventional susceptible

232 cells, induced by tetanus toxoid (TT), human thyroglobulin (TG), Escherichia coli LPS, or intact Porp

233 ance, the thyroid hormone precursor protein, thyroglobulin (Tg), has been experimentally investigated

234 iditis, induced in mice after challenge with thyroglobulin (Tg), is known to be under the genetic con

235 Moreover, it is inducible with thyroglobulin (Tg), the common autoantigen in either spe

236 Thyroglobulin (Tg), the major protein secreted by thyroi

237 Newly synthesized thyroglobulin (Tg), the major secretory glycoprotein of

238 Thyroglobulin (TG), the primary synthetic product of the

239 Newly synthesized thyroglobulin (Tg), the secretory glycoprotein that serv

240 Thyroglobulin (Tg), the thyroid hormone precursor, is a

241 Newly synthesized thyroglobulin (Tg), the thyroid prohormone, forms detect

242 Detection of mRNA transcripts for thyroglobulin (TG), thyroid peroxidase (TPO) and RET/PTC

243 Polyreactive and thyroglobulin (Tg)-directed proteolytic activities prese

244 nts included response correlation with serum thyroglobulin (Tg); functional imaging; tumor genotype;

245 Secretion of thyroglobulin (Tg, a large homodimeric glycoprotein) is

246 Thyroglobulin (Tg, precursor for thyroid hormone synthes

247 In humans, deficient thyroglobulin (Tg, the thyroid prohormone) is an importa

248 FT3], thyroid-stimulating hormone [TSH], and thyroglobulin [Tg]) and levels of Pb, Hg, and Cd in bloo

249 t was performed for bovine serum albumin and thyroglobulin that required gradient separations.

250 TSH regulates post-translational changes in thyroglobulin that selectively enhance its capacity for

251 are now known to exist in TG (encoding human thyroglobulin) that can lead to defective thyroid hormon

252 pression of thyroid differentiation markers, thyroglobulin, thyroid-stimulating hormone receptor, thy

253 SH and the agonists increase mRNA levels for thyroglobulin, thyroperoxidase, sodium iodide symporter,

254 ained significantly lower levels of AIRE and thyroglobulin, to which tolerance is typically lost in a

255 ction including thyroid-stimulating hormone, thyroglobulin, total and free thyroxine, and total and f

256 Upon immunization with murine thyroglobulin, transgenic mice developed milder disease

257 by expression of cytokeratin 18, E-cadherin, thyroglobulin, TTF-1 and Pax-8 proteins.

258 er, we surmise that in the natural precursor thyroglobulin, two evolutionary late and slower hormonog

259 domain (GA733 type 1 motif), a cysteine-rich thyroglobulin type 1A domain (GA733 type 2 motif), and a

260 recently determined disulfide pattern of the thyroglobulin type 1A domain of insulin-like growth fact

261 ar calcium-binding (EC) domain(s) and 1 or 2 thyroglobulin type-1 (TY) domain(s).

262 ing hormone (TSH), free thyroxine (FT4), and thyroglobulin, vary widely due to variability in the com

263 amined for BRAF and RAS mutations, and serum thyroglobulin was measured at baseline and at each visit

264 ccal vaccines; and autoantibodies to DNA and thyroglobulin were assessed before and after supplementa

265 The immune responses to neu or thyroglobulin were greater in mice undergoing TUBO tumor

266 lum-associated protein degradation of mutant thyroglobulin, whereas degradation of a nonglycosylated

267 ons (thyroid extract, desiccated thyroid, or thyroglobulin), which contain both thyroxine (T4) and tr

268 timulated secretion of the secretory protein thyroglobulin with an efficiency similar to that of wild

269 60 fullerene derivative conjugated to bovine thyroglobulin yielded a population of fullerene-specific